Junshi Biosciences has invested in the University of Birmingham-founded cancer immunotherapy developer, building on a research collaboration deal.

Blue Venture Fund returned as part of the latest funding to be raised by the mobile substance abuse treatment service.

Amazon Climate Pledge Fund and Shell Ventures both participated in a $21.4m round that will support development of ZeroAvia's hydrogen aircraft powertrain.

The Recruit-backed second-hand luxury goods marketplace had added an eight-figure dollar amount to the $20m it raised last year.

The Tencent and CNP Assurances-backed round has been boosted by $86m and the banking app developer has now pulled in over $160m in total.

The exosite drug developer has launched publicly to advance research from Harvard University and Salk Institute for Biological Studies.

Mayo Clinic had invested in and partnered the medical data software provider before joining a series C round also featuring NTTVC.

Returning investor Sammons Financial contributed to a round that more than doubled the online life insurer's total funding to $145m.

Novartis Venture Fund is among the participants in a series A round disclosed by the exosite drug developer at its public launch.

The WuXi AppTec-backed cancer drug developer has now raised $70m in total as it prepares to bring its lead candidate into the clinic.